Actively Recruiting

Phase Not Applicable
Age: 7Years - 16Years
All Genders
ID06770010

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell (ALL IN)

Led by Children's National Research Institute · Updated on 2025-02-13

50

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating a new approach to improve cognitive skills in children and adolescents aged 7 to 16 years with sickle cell disease (SCD). This trial focuses on addressing working memory deficits, a common cognitive challenge in youth with SCD, who are at risk of neurological issues even without stroke. The study evaluates a combined treatment involving digital working memory training, social support, and memory strategy coaching to enhance engagement and adherence to the training. The treatment involves a home-based digital program called Cogmed+, which includes working memory exercises on a tablet device that participants complete 3 to 5 times weekly for 5 to 8 weeks. Participants attend weekly videoconference sessions with a coach who reviews progress and teaches memory strategies during four coaching calls. The program also includes social support through family kickoff events, social incentives, and peer navigator assistance. The study compares outcomes to a previous group who used the basic Cogmed program. Participants will undergo cognitive screening to identify those with working memory challenges who then proceed to the Cogmed+ program. Researchers will monitor adherence by measuring the number of completed training sessions, attendance at kickoff events, and participation in memory strategy training. The study will assess feasibility and acceptability of this enhanced program and aims to inform future larger trials. Total participation spans approximately 5 to 8 weeks of training plus follow-up assessments.

CONDITIONS

Brief Title

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

Who Can Participate

Age: 7Years - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of sickle cell disease (any genotype)
  • Between ages 7 and 16 years old
  • Working memory difficulties shown by scoring more than 1 standard deviation below the norm on specific memory tests or relative weakness compared to IQ
Not Eligible

You will not qualify if you...

  • Motor, visual, or hearing impairments that prevent computer use
  • Mental health conditions that prevent or take precedence over cognitive training participation
  • History of seizures triggered by flashing lights (photosensitive seizures)
  • Insufficient fluency in English
  • Recent start or dose change of stimulant medication for attention issues within the past 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 5 to 8 weeks

Participants complete the Cogmed+ digital working memory training program at home and attend weekly videoconference coaching calls to review progress and learn memory strategies. Social support is provided through kickoff events, social incentives, and peer navigator support.

Weekly videoconference coaching calls and 1 to 3 social support events

Trial Site Locations

Total: 1 location

1

Children's National Hospital

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

Loading map...

Research Team

S

Steven Hardy, PhD

S

Sara Ropeta, BS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Long-term Follow-up Study in Patients With Hemoglobinopath...

Hemoglobinopathy

Actively Recruiting

17 locations

A Phase 1b Study of the Safety, Tolerability, Pharmacokineti...

Sickle Cell Disease

Actively Recruiting

7 locations

A Phase 2 Open-label Study to Evaluate the Activity of Etavo...

Sickle Cell Disease

Actively Recruiting

9 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here